Drugs & Targets Keytruda’s sBLA receives Priority Review from FDA for second-line treatment of relapsed or refractory classical Hodgkin lymphoma July 10, 2020Vol.46 No.28
Drugs & Targets Lynparza approved in EU for germline BRCA-mutated metastatic pancreatic cancer July 10, 2020Vol.46 No.28
Clinical Roundup Drug screens and CRISPR combine to make better cancer drugs, collaboration of researchers say July 10, 2020Vol.46 No.28
Clinical Roundup Fasting Mimicking Diets may enhance effectiveness of chemotherapy in cancer patients July 10, 2020Vol.46 No.28
Funding Opportunities DoD Pancreatic Cancer Research Program funding opportunities for FY20 July 10, 2020Vol.46 No.28
Funding Opportunities Defense Health Program DoD Rare Cancers Research Program anticipated funding opportunities for FY20 July 10, 2020Vol.46 No.28
In Brief Theoret, Beaver, Kim, Amiri-Kordestani named to new positions at FDA July 10, 2020Vol.46 No.28
In Brief Müschen named director of Center of Molecular and Cellular Oncology at Yale July 10, 2020Vol.46 No.28
In Brief Friedman named associate director for community science and health outcomes at Vanderbilt July 10, 2020Vol.46 No.28
In Brief Mehnert joins NYU Langone as associate director, clinical research July 10, 2020Vol.46 No.28
